LYEL
LYEL

Lyell Immunopharma Inc

NASDAQ · Biotechnology
$22.71
+0.07 (+0.31%)
Analyst Consensus
Strong Buy
9 analysts
Buy 7 78%
Hold 1 11%
Sell 1 11%
Price Target
Analyst Price Target +23.1% upside
Low Target $18.45
Average Target $27.95
High Target $35.39
Current Price $22.71
Current
$22.71
Target
$27.95
$18.45 $27.95 avg $35.39